Evidence method
Level · gp.fundamentals.capex_revenue_ratio
99.70% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ABCL · Sep 30, 2025
AbCellera Biologics Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001703057-25-000025General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-587.31% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
37.62% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-851.79% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
614.49% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
155.15% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History18 statesSelf-history eligible
Mar 31, 20220/6 normalizedLevel 3Jun 30, 20220/6 normalizedLevel 3Sep 30, 20220/6 normalizedLevel 3Dec 31, 20220/6 normalizedLevel 3Mar 31, 20235/6 normalizedLevel 3Jun 30, 20235/6 normalizedLevel 3Sep 30, 20235/6 normalizedLevel 3Dec 31, 20235/6 normalizedLevel 3Mar 31, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedLevel 3Sep 30, 20246/6 normalizedLevel 3Dec 31, 20246/6 normalizedLevel 3Mar 31, 20256/6 normalizedLevel 3Jun 30, 20256/6 normalizedLevel 3Sep 30, 20256/6 normalizedLevel 3Dec 31, 20256/7 normalizedLevel 3Mar 31, 20266/7 normalizedLevel 3Jun 30, 20266/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 78.23%
- Current
- 99.70%
- Delta
- 21.47%
- Previous
- -189.67%
- Current
- -587.31%
- Delta
- -397.64%
- Previous
- 133.29%
- Current
- 37.62%
- Delta
- -95.67%
- Previous
- -290.24%
- Current
- -851.79%
- Delta
- -561.55%
- Previous
- 229.53%
- Current
- 614.49%
- Delta
- 384.96%
- Previous
- 83.17%
- Current
- 155.15%
- Delta
- 71.99%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · ABCL Fundamental State →Transitioned To · ABCL Fundamental State →Transitioned To · ABCL CAPEX_INTENSITY_INCREASED →Transitioned To · ABCL CASH_GENERATION_DECREASED →Transitioned To · ABCL GROWTH_DECREASED →Transitioned To · ABCL PROFITABILITY_DECREASED →Transitioned To · ABCL R_AND_D_INTENSITY_INCREASED →Transitioned To · ABCL SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.